
SweetBio
Biotech startup revolutionizing healing, starting in oral surgery.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | - | ||
Total Funding | 000k |
Related Content
SweetBio is a healthcare company specializing in bioengineered wound care products designed to manage chronic and acute wounds. Their flagship product, APIS, is a bioengineered wound dressing that covers and protects wounds, absorbs exudate, and creates a moist environment conducive to healing. The product's in vitro data demonstrates its ability to reduce bacterial load, decrease MMP 9, and trigger the release of growth factors, which collectively help balance the wound environment and promote healing. SweetBio primarily serves healthcare providers and patients dealing with complex wound care needs. Operating in the medical device market, the company employs a business model that includes direct sales to healthcare facilities and partnerships with medical distributors. Revenue is generated through the sale of their APIS product line, which is available in multiple sizes and is shelf-stable at room temperature. The company is headquartered in Memphis, TN, and continues to innovate in the field of wound care management.
Keywords: bioengineered, wound care, chronic wounds, acute wounds, bacterial load, MMP 9, growth factors, healthcare, medical device, Memphis